[HTML][HTML] Bioactives from mushroom: health attributes and food industry applications

A Bains, P Chawla, S Kaur, A Najda, M Fogarasi… - Materials, 2021 - mdpi.com
It is well-known that the utilization of mushrooms as therapeutic agents is not new. Over the
past years, they have been used by local individuals as food, as well as medicines …

Worldwide control and management of Chagas disease in a new era of globalization: a close look at congenital Trypanosoma cruzi infection

A Abras, C Ballart, A Fernández-Arévalo… - Clinical microbiology …, 2022 - Am Soc Microbiol
Population movements have turned Chagas disease (CD) into a global public health
problem. Despite the successful implementation of subregional initiatives to control vectorial …

Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial

CA Morillo, H Waskin, S Sosa-Estani… - Journal of the American …, 2017 - jacc.org
Background: Benznidazole is recommended for treatment of Chagas infection. Effects of
combination therapy with benznidazole and posaconazole have not been tested in …

The role of imidazole and benzimidazole heterocycles in Chagas disease: A review

I Beltran-Hortelano, V Alcolea, M Font… - European journal of …, 2020 - Elsevier
The haemoflagellate protozoan Trypanosoma cruzi (T. cruzi) is the causative agent of
Chagas disease (CD), a potentially life-threatening disease. Little by little, remarkable …

Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review

SS Santos, RV de Araújo, J Giarolla, O El Seoud… - International journal of …, 2020 - Elsevier
Chagas disease, leishmaniasis and schistosomiasis are neglected diseases (NDs) and are
a considerable global challenge. Despite the huge number of people infected, NDs do not …

The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets

F Altamura, R Rajesh, CMC Catta‐Preta… - Drug development …, 2022 - Wiley Online Library
Human trypanosomiasis and leishmaniasis are vector‐borne neglected tropical diseases
caused by infection with the protozoan parasites Trypanosoma spp. and Leishmania spp …

[HTML][HTML] Treatment of Chagas disease in the United States

S Meymandi, S Hernandez, S Park… - … treatment options in …, 2018 - Springer
Abstract Purpose of Review Chagas disease (CD) is endemic to much of Latin America, but
also present in the United States (US). Following a lengthy asymptomatic period, CD …

[HTML][HTML] Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease

I Beltran-Hortelano, V Alcolea, M Font… - Bioorganic & medicinal …, 2022 - Elsevier
Chagas disease (CD) is a centenarian neglected parasitosis caused by the protozoan
Trypanosoma cruzi (T. cruzi). Despite the continuous efforts of many organizations and …

Nitriles: an attractive approach to the development of covalent inhibitors

V Bonatto, RF Lameiro, FR Rocho, J Lameira… - RSC Medicinal …, 2023 - pubs.rsc.org
Nitriles have broad applications in medicinal chemistry, with more than 60 small molecule
drugs on the market containing the cyano functional group. In addition to the well-known …

Artemisinin and its derivatives in treating protozoan infections beyond malaria

CSN Loo, NSK Lam, D Yu, X Su, F Lu - Pharmacological research, 2017 - Elsevier
Parasitic protozoan diseases continue to rank among the world's greatest global health
problems, which are also common among poor populations. Currently available drugs for …